A conceptual framework for prognostic research.

Association Causality Prediction Prognosis

Journal

BMC medical research methodology
ISSN: 1471-2288
Titre abrégé: BMC Med Res Methodol
Pays: England
ID NLM: 100968545

Informations de publication

Date de publication:
29 06 2020
Historique:
received: 25 09 2019
accepted: 12 06 2020
entrez: 1 7 2020
pubmed: 1 7 2020
medline: 25 6 2021
Statut: epublish

Résumé

Prognostic research has many important purposes, including (i) describing the natural history and clinical course of health conditions, (ii) investigating variables associated with health outcomes of interest, (iii) estimating an individual's probability of developing different outcomes, (iv) investigating the clinical application of prediction models, and (v) investigating determinants of recovery that can inform the development of interventions to improve patient outcomes. But much prognostic research has been poorly conducted and interpreted, indicating that a number of conceptual areas are often misunderstood. Recent initiatives to improve this include the Prognosis Research Strategy (PROGRESS) and the Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD) Statement. In this paper, we aim to show how different categories of prognostic research relate to each other, to differentiate exploratory and confirmatory studies, discuss moderators and mediators, and to show how important it is to understand study designs and the differences between prediction and causation. We propose that there are four main objectives of prognostic studies - description, association, prediction and causation. By causation, we mean the effect of prediction and decision rules on outcomes as determined by intervention studies and the investigation of whether a prognostic factor is a determinant of outcome (on the causal pathway). These either fall under the umbrella of exploratory (description, association, and prediction model development) or confirmatory (prediction model external validation and investigation of causation). Including considerations of causation within a prognostic framework provides a more comprehensive roadmap of how different types of studies conceptually relate to each other, and better clarity about appropriate model performance measures and the inferences that can be drawn from different types of prognostic studies. We also propose definitions of 'candidate prognostic factors', 'prognostic factors', 'prognostic determinants (causal)' and 'prognostic markers (non-causal)'. Furthermore, we address common conceptual misunderstandings related to study design, analysis, and interpretation of multivariable models from the perspectives of association, prediction and causation. This paper uses a framework to clarify some concepts in prognostic research that remain poorly understood and implemented, to stimulate discussion about how prognostic studies can be strengthened and appropriately interpreted.

Sections du résumé

BACKGROUND
Prognostic research has many important purposes, including (i) describing the natural history and clinical course of health conditions, (ii) investigating variables associated with health outcomes of interest, (iii) estimating an individual's probability of developing different outcomes, (iv) investigating the clinical application of prediction models, and (v) investigating determinants of recovery that can inform the development of interventions to improve patient outcomes. But much prognostic research has been poorly conducted and interpreted, indicating that a number of conceptual areas are often misunderstood. Recent initiatives to improve this include the Prognosis Research Strategy (PROGRESS) and the Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD) Statement. In this paper, we aim to show how different categories of prognostic research relate to each other, to differentiate exploratory and confirmatory studies, discuss moderators and mediators, and to show how important it is to understand study designs and the differences between prediction and causation.
MAIN TEXT
We propose that there are four main objectives of prognostic studies - description, association, prediction and causation. By causation, we mean the effect of prediction and decision rules on outcomes as determined by intervention studies and the investigation of whether a prognostic factor is a determinant of outcome (on the causal pathway). These either fall under the umbrella of exploratory (description, association, and prediction model development) or confirmatory (prediction model external validation and investigation of causation). Including considerations of causation within a prognostic framework provides a more comprehensive roadmap of how different types of studies conceptually relate to each other, and better clarity about appropriate model performance measures and the inferences that can be drawn from different types of prognostic studies. We also propose definitions of 'candidate prognostic factors', 'prognostic factors', 'prognostic determinants (causal)' and 'prognostic markers (non-causal)'. Furthermore, we address common conceptual misunderstandings related to study design, analysis, and interpretation of multivariable models from the perspectives of association, prediction and causation.
CONCLUSION
This paper uses a framework to clarify some concepts in prognostic research that remain poorly understood and implemented, to stimulate discussion about how prognostic studies can be strengthened and appropriately interpreted.

Identifiants

pubmed: 32600262
doi: 10.1186/s12874-020-01050-7
pii: 10.1186/s12874-020-01050-7
pmc: PMC7325141
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

172

Références

BMC Public Health. 2014 Jan 08;14:14
pubmed: 24400816
J Clin Epidemiol. 2012 Dec;65(12):1257-66
pubmed: 22959592
BMJ. 2009 Mar 31;338:b604
pubmed: 19336487
J Clin Epidemiol. 2008 Jun;61(6):552-60
pubmed: 18471659
J Physiother. 2018 Jan;64(1):16-23
pubmed: 29289589
Epidemiology. 2010 Jan;21(1):128-38
pubmed: 20010215
Arch Phys Med Rehabil. 2014 Mar;95(3 Suppl):S101-31
pubmed: 24581901
Spine (Phila Pa 1976). 2010 Aug 1;35(17):E827-35
pubmed: 20628331
PLoS Med. 2013;10(2):e1001380
pubmed: 23393429
PLoS Med. 2014 Jul 08;11(7):e1001671
pubmed: 25003600
BMJ. 2009 Feb 23;338:b375
pubmed: 19237405
Arch Gen Psychiatry. 2002 Oct;59(10):877-83
pubmed: 12365874
Br J Cancer. 2015 Dec 22;113(12):1746
pubmed: 26695557
J Clin Epidemiol. 1996 Aug;49(8):907-16
pubmed: 8699212
BMJ. 2009 Jun 04;338:b606
pubmed: 19502216
Arthritis Rheum. 2008 May 15;59(5):632-41
pubmed: 18438893
J Manipulative Physiol Ther. 2009 Feb;32(2 Suppl):S117-40
pubmed: 19251060
J Rehabil Med. 2004 Feb;(43 Suppl):84-105
pubmed: 15083873
Spine (Phila Pa 1976). 2006 Feb 15;31(4):468-72
pubmed: 16481960
PLoS Med. 2012;9(5):1-12
pubmed: 22629234
PLoS Med. 2013;10(2):e1001381
pubmed: 23393430
BMJ. 2019 Jan 30;364:k4597
pubmed: 30700442
BMC Med. 2015 Jan 30;13:20
pubmed: 25637245
Heart. 2012 May;98(9):691-8
pubmed: 22397946
Disabil Rehabil. 2015;37(6):471-89
pubmed: 24963833
Circulation. 2010 Jun 1;121(21):2271-83
pubmed: 20479151
Ann Intern Med. 2015 Jan 6;162(1):W1-73
pubmed: 25560730
Lancet. 2011 Oct 29;378(9802):1560-71
pubmed: 21963002
BMC Med. 2012 May 29;10:51
pubmed: 22642691
Curr Drug Saf. 2013 Nov;8(5):333-48
pubmed: 24215311
PLoS Med. 2014 Oct 14;11(10):e1001744
pubmed: 25314315
BMJ. 2013 Feb 05;346:e5595
pubmed: 23386360
BMJ. 2013 Feb 05;346:e5793
pubmed: 23386361
J Physiother. 2014 Dec;60(4):241-4
pubmed: 25443537
Am J Psychiatry. 2001 Jun;158(6):848-56
pubmed: 11384888
Spine (Phila Pa 1976). 2008 Feb 15;33(4 Suppl):S83-92
pubmed: 18204405
Ann Fam Med. 2014 Mar-Apr;12(2):102-11
pubmed: 24615305
BMJ. 2009 Dec 30;339:b4184
pubmed: 20042483
Spine (Phila Pa 1976). 2008 Feb 15;33(4 Suppl):S5-7
pubmed: 18204400
BMC Musculoskelet Disord. 2018 Sep 11;19(1):326
pubmed: 30205812
Spine (Phila Pa 1976). 2001 Oct 1;26(19):E445-58
pubmed: 11698904
BMJ. 2009 May 28;338:b605
pubmed: 19477892
Nat Clin Pract Urol. 2005 Aug;2(8):416-22
pubmed: 16482653
Arch Phys Med Rehabil. 2014 Mar;95(3 Suppl):S265-77
pubmed: 24581912
Br J Cancer. 2010 Jan 5;102(1):173-80
pubmed: 19997101
Adv Anat Pathol. 2015 Sep;22(5):303-5
pubmed: 26262512

Auteurs

Peter Kent (P)

School of Physiotherapy and Exercise Science, Curtin University, Kent St, Bentley, Perth, WA 6102, Australia. peter.kent@curtin.edu.au.
Department of Sports Science and Clinical Biomechanics, University of Southern Denmark, Odense, Denmark. peter.kent@curtin.edu.au.

Carol Cancelliere (C)

Faculty of Health Sciences, Ontario Tech University, Oshawa, Ontario, Canada.
Centre for Disability Prevention and Rehabilitation, Ontario Tech University and the Canadian Memorial Chiropractic College, Toronto, Ontario, Canada.

Eleanor Boyle (E)

Department of Sports Science and Clinical Biomechanics, University of Southern Denmark, Odense, Denmark.

J David Cassidy (JD)

Division of Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.

Alice Kongsted (A)

Department of Sports Science and Clinical Biomechanics, University of Southern Denmark, Odense, Denmark.
Nordic Institute of Chiropractic and Clinical Biomechanics, Odense, Denmark.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH